Tolvaptan vs. furosemide-based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA-AHF).

Tien M H NgLuanda P GrazetteMichael W FongAndrew J YoonMimi LouAllen KuoRani Y UpadhyayEmily E HanAnilkumar MehraUri Elkayam

Published in: ESC heart failure (2020)

Oral tolvaptan was associated with similar, but not superior, diuresis compared with intravenous furosemide for acute heart failure with concomitant hyponatremia.

Keyphrases

acute heart failure
heart failure
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
atrial fibrillation
left ventricular
patient reported outcomes